The company now has FDA clearance for five different applications on Iris — cardiac, lung, bladder, hip and thyroid. It expects to double that number by 2025.
Iris delivers high-performance medical imaging at a fraction of the size and cost of cart-based ultrasound. The system, built on Exo’s advanced silicon technology, fits in the pockets of caregivers. It enables immediate answers at the point of care for physicians, nurses, EMTs and clinicians in emergency, acute care, outpatient and home settings.
Exo unveiled the device for versatile imaging performance in point-of-care ultrasound (POCUS) in September 2023.
The company says the launch of its latest Iris functions simplify the process of obtaining and interpreting images specific to the heart and lungs. This allows caregivers — particularly in rural and under-resourced settings — to accelerate diagnosis and treatment regardless of location.
“It’s time for a reimagined approach to addressing heart failure at scale. That’s why Exo is putting AI-empowered medical imaging in the hands of every caregiver, no matter their specialty,” said Sandeep Akkaraju, co-founder and CEO of Exo. “Exo’s AI is simple to use, reproducible and objective, and will contribute to more accessible and reliable healthcare for all.”
More about the Exo AI applications
The company said it trains its AI applications on more than 100,000 images from POCUS exams from real-world settings. Exo says its AI recognizes internal landmarks on less-than-perfect scans, enabling caregivers to acquire the real-time data needed to make informed decisions without lab-quality ultrasounds.
With a quick scan, Exo’s lung AI reliably identifies the presence of B-lines. This enables users to quickly assess the patient for pulmonary edema or fluid in the lungs. With cardiac AI, it can quickly measure left ventricle ejection fraction (LVEF) and stroke volume in a few heartbeats in both parasternal long axis (PLAX) and apical four-chamber (A4C) views.
In addition to the latest AI applications, Iris now features pulsed-wave doppler capabilities. This provides physicians with even more opportunities to look at blood velocity to support diagnosis in cardiac, abdominal and vascular applications.
